Group One Trading
ROIV icon

Group One Trading’s Roivant Sciences ROIV Stock Holding History

Group One Trading’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.89M Buy
110,000
+82,900
+306% +$2.45M 0.01% 1626
2026
Q1 		$751K Sell
27,100
-700,400
-96% -$18M ﹤0.01% 2962
2025
Q4 		$15.8M Buy
727,500
+30,900
+4% +$610K 0.03% 669
2025
Q3 		$10.5M Buy
696,600
+643,700
+1,217% +$7.97M 0.02% 873
2025
Q2 		$596K Buy
52,900
+22,700
+75% +$246K ﹤0.01% 3235
2025
Q1 		$305K Sell
30,200
-87,400
-74% -$945K ﹤0.01% 3566
2024
Q4 		$1.39M Sell
117,600
-24,500
-17% -$290K ﹤0.01% 2244
2024
Q3 		$1.64M Sell
142,100
-4,600
-3% -$52.4K ﹤0.01% 1882
2024
Q2 		$1.55M Buy
146,700
+86,600
+144% +$949K 0.01% 1649
2024
Q1 		$633K Sell
60,100
-460,700
-88% -$4.97M ﹤0.01% 2510
2023
Q4 		$5.85M Buy
520,800
+213,500
+69% +$2.08M 0.02% 1016
2023
Q3 		$3.59M Buy
307,300
+268,100
+684% +$3.03M 0.01% 1163
2023
Q2 		$395K Sell
39,200
-14,200
-27% -$127K ﹤0.01% 3250
2023
Q1 		$394K Sell
53,400
-9,200
-15% -$75.8K ﹤0.01% 2985
2022
Q4 		$500K Buy
+62,600
New +$348K ﹤0.01% 3042

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Group One Trading's ROIV Position: Q2 2026 in Review

Group One Trading increased its Roivant Sciences (ROIV) stake by 98% in Q2 2026, buying an estimated $1.13M and bringing the position to 77,622 shares worth $2.75M. The position accounts for ﹤0.01% of the portfolio, ranked #1930.

Group One Trading first reported a position in ROIV in Q3 2022 and has held it in 9 quarters since. 500 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Group One Trading held 77,622 shares of Roivant Sciences worth $2.75M as of Q2 2026.
  • Group One Trading bought 38,350 Roivant Sciences shares in Q2 2026, an estimated $1.13M.
  • Roivant Sciences made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #1930 holding.
  • Group One Trading first reported a position in Roivant Sciences in Q3 2022 and has held it in 9 quarters since.
  • 500 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.